Boston Scientific Acquires Axonics, Inc.

Axonius Acquires Cynerio

July 30, 2025

Cybersecurity

Axonius has acquired Cynerio, a specialist in medical-device and healthcare IoT security, to accelerate the company's expansion into the healthcare market. Deal terms were reported at about $180 million (potentially rising to $250 million on milestones), while Axonius' announcement described the transaction as "more than $100 million" in a cash-and-stock deal.

Axonics Acquires Contura Ltd (Bulkamid)

February 25, 2021

Medical Devices

Axonics Modulation Technologies, Inc. acquired London-based Contura Ltd. and its Bulkamid urethral bulking agent for $200 million in cash and stock plus a potential $35 million milestone. The acquisition expands Axonics' portfolio into stress urinary incontinence (SUI), leverages its commercial footprint in the U.S. and Europe, and is expected to be immediately accretive to Axonics' financial results.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition is expected to expand Boston Scientific’s electrophysiology and structural heart portfolios by adding the RF NRG and VersaCross transseptal platforms and related guidewires, sheaths, and dilators.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.

Medtronic to Acquire Scientia Vascular for $550 Million

March 10, 2026

Healthcare Services

Medtronic entered into a definitive agreement to acquire Scientia Vascular in a deal valued at $550 million, subject to customary adjustments and potential earn-out/milestone payments. The acquisition is expected to close in the first half of Medtronic’s fiscal 2027, pending regulatory approvals and other closing conditions.

Boston Scientific Announces Agreement to Acquire Cortex, Inc.

November 4, 2024

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company, to complement its electrophysiology portfolio with Cortex’s diagnostic mapping technology for complex atrial fibrillation. Cortex’s OptiMap System uses a basket catheter and proprietary algorithm to identify atrial fibrillation triggers outside the pulmonary veins, which is intended to support more targeted ablation strategies.